Targiniq has been used in Europe for 8 yrs and is an anti-OIC co-drug and like Suboxone does zero to curb abuse euphoria. Why now when Purdue ask to distribute Targiniq in the USA does the FDA agreed????
Dr. Andrew Kolodny in stating that Targiniq is an "empty gimmick" is absolutely correct
Even worse Suboxone detox clinics know that "Savvy Street Junkies" can easily separate out the Naloxone and leave the pure agonist CIII Buprenorphine, due to the solubility characteristics and a very short half life of the Naloxone. So too will be the case for Targiniq, but even more dangerous, the freed CII Oxycodone agonist will lead to respiratory arrest deaths.
Simply shameful that "empty gimmick" FDA has flabbergastedly committed another Zohydro debacle!
News 
Market Data 
Discover 
AI
